{"title":"Promising results for quizartinib, venetoclax, and decitabine in FLT3-ITD mutated AML","authors":"Robert van den Heuvel","doi":"10.55788/2ce7b468","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"277 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicom Conference Report ASH 2023","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55788/2ce7b468","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}